Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18975)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2019 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol 2019; 25(2): 163-177 [PMID: 30670907 DOI: 10.3748/wjg.v25.i2.163] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i2/163.htm |
| Number | Citing Articles |
| 1 |
Eleftheria Ztriva, Adonis Protopapas, Pavlos Mentizis, Anastasios Papadopoulos, Christiana Gogou, Maria Kiosi, Maria Kyziroglou, Ioanna Minopoulou, Anastasia Gkounta, Erofili Papathanasiou, Evangelos Cholongitas, Christos Savopoulos, Konstantinos Tziomalos. Hepatic Fibrosis Is a Risk Factor for Greater Severity and Worse Outcome of Acute Ischemic Stroke. Journal of Clinical Medicine 2022; 11(17): 5141 doi: 10.3390/jcm11175141
|
| 2 |
Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4570219
|
| 3 |
Qian Yu, Yann-yin Lee, Zheng-yun Xia, Emily C. Liong, Jia Xiao, George L. Tipoe. S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation. European Journal of Nutrition 2021; 60(2): 961 doi: 10.1007/s00394-020-02305-1
|
| 4 |
Manoj K. Mahapatra, Muthukumar Karuppasamy, Biswa M. Sahoo. Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review. Pharmaceutical Research 2022; 39(6): 1233 doi: 10.1007/s11095-022-03302-1
|
| 5 |
Momoko Hayashi, Yoshibumi Kuwabara, Kuniji Ito, Yoshiaki Hojo, Fumiaki Arai, Kazuki Kamijima, Masakazu Takeiri, Xiaojing Wang, Pan Diao, Jun Nakayama, Naoki Tanaka. Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. Biomedicines 2023; 11(2): 384 doi: 10.3390/biomedicines11020384
|
| 6 |
J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar. Actas Dermo-Sifiliográficas 2023; 114(5): 392 doi: 10.1016/j.ad.2023.01.004
|
| 7 |
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Yasuyuki Ichise, Kenji Sano, Akira Horiuchi. Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy. World Journal of Hepatology 2020; 12(9): 685-692 doi: 10.4254/wjh.v12.i9.685
|
| 8 |
Yongli Zhang, Fangru Zhou, Hong Yang, Xue Gong, Jingfang Gao, Bhagyaveni M.A. Current Status of Fear of Disease Progression in Patients with Advanced Cancer and Usefulness of Dignity Therapy Intervention. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/6069060
|
| 9 |
Gong Feng, Luca Valenti, Vincent Wai-Sun Wong, Yasser Mahrous Fouad, Yusuf Yilmaz, Won Kim, Giada Sebastiani, Zobair M. Younossi, Virginia Hernandez-Gea, Ming-Hua Zheng. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2024; 21(1): 46 doi: 10.1038/s41575-023-00846-4
|
| 10 |
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
|
| 11 |
Jing-ping Zhou, Yan-dan Ren, Qin-yu Xu, Yang Song, Fei Zhou, Mei-Ya Chen, Jing-jing Liu, Li-Gang Chen, Jin-Shui Pan. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4087928
|
| 12 |
Qinghui Niu, Ting Wang, Zhiqiang Wang, Feng Wang, Deyu Huang, Huali Sun, Hanyun Liu. Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p. Adipocyte 2022; 11(1): 572 doi: 10.1080/21623945.2022.2098583
|
| 13 |
R. V. Yanko, E. G. Chaka, A. S. Zinchenko, S. L. Safonov, M. L. Levashov. Features of modeling fatty liver disease in rats of different ages based on a high-calorie diet. Obesity and metabolism 2022; 18(4): 387 doi: 10.14341/omet12789
|
| 14 |
Ruifang Li, Jie Liu, Ping Han, Ruifang Shi, Lili Zhao, Jia Li. Associations between abdominal obesity indices and pathological features of non‐alcoholic fatty liver disease: Chinese visceral adiposity index. Journal of Gastroenterology and Hepatology 2023; 38(8): 1316 doi: 10.1111/jgh.16196
|
| 15 |
Takefumi Kimura, Takanobu Iwadare, Shun‐ichi Wakabayashi, Seema Kuldeep, Tomoyuki Nakajima, Tomoo Yamazaki, Daiki Aomura, Hamim Zafar, Mai Iwaya, Satoru Joshita, Takeshi Uehara, Sai P. Pydi, Naoki Tanaka, Takeji Umemura. Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease. Liver International 2024; 44(2): 483 doi: 10.1111/liv.15792
|
| 16 |
Chrong-Reen Wang, Hung-Wen Tsai. Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 2022; 28(23): 2527-2545 doi: 10.3748/wjg.v28.i23.2527
|
| 17 |
Haoran Jiang, Linquan Zang. GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD. Current Pharmaceutical Design 2024; 30(2): 100 doi: 10.2174/0113816128283153231226103218
|
| 18 |
Dhaval Oza, Mansoor M. Amiji. Macrophage Targeted Delivery Systems. 2022; : 357 doi: 10.1007/978-3-030-84164-5_16
|
| 19 |
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura. Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease. Communications Medicine 2024; 4(1) doi: 10.1038/s43856-024-00499-7
|
| 20 |
Tiefeng Zhang, Duan Han, Tianqi Zhang, Cai Jing, Jianguang Sun. Complementary and alternative therapies for non-alcoholic fatty liver disease. Medicine 2021; 100(4): e24432 doi: 10.1097/MD.0000000000024432
|
| 21 |
Amy E. McGhee-Jez, Inna Chervoneva, Misung Yi, Amisha Ahuja, Ritu Nahar, Samik Shah, Rebecca Loh, Sarah Houtmann, Rashesh Shah, Charles J. Yeo, Harish Lavu, Steven J. Cohen, Dina Halegoua-DeMarzio, Atrayee Basu Mallick. Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis. Journal of Pancreatic Cancer 2021; 7(1): 23 doi: 10.1089/pancan.2020.0006
|
| 22 |
Yan Lv, Hai-jun Zhang. Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00251
|
| 23 |
Ashvin Bashyam, Chris J. Frangieh, Siavash Raigani, Jeremy Sogo, Roderick T. Bronson, Korkut Uygun, Heidi Yeh, Dennis A. Ausiello, Michael J. Cima. A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis. Nature Biomedical Engineering 2020; 5(3): 240 doi: 10.1038/s41551-020-00638-0
|
| 24 |
Ran An, Shuai Wen, Dong-Li Li, Qiu-Hua Li, Xing-Fei Lai, Wen-Ji Zhang, Ruo-Hong Chen, Jun-Xi Cao, Zhi-Gang Li, Qiu-Sheng Huang, Ling-Li Sun, Shi-Li Sun. Mixtures of Tea andCitrus maxima(pomelo) Alleviate Lipid Deposition in HepG2 Cells Through the AMPK/ACC Signaling Pathway. Journal of Medicinal Food 2020; 23(9): 943 doi: 10.1089/jmf.2020.4706
|
| 25 |
Saana Eskelinen, Janne V. J. Suvisaari, Jaana M. Suvisaari. Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening tests. Annals of General Psychiatry 2020; 19(1) doi: 10.1186/s12991-020-00321-3
|
| 26 |
Naoyuki Fujimori, Naoki Tanaka, Takefumi Kimura, Kenji Sano, Akira Horiuchi, Naoyuki Kato, Yoshiyuki Takahashi, Naoya Kuribayashi, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus. Clinical Journal of Gastroenterology 2020; 13(1): 83 doi: 10.1007/s12328-019-01018-1
|
| 27 |
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4): 750 doi: 10.14366/usg.21182
|
| 28 |
Yuping Zeng, He He, Zhenmei An, Jin Chai. Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1254014
|
| 29 |
Cornelius J. Fernandez, Mohammed Alkhalifah, Hafsa Afsar, Joseph M. Pappachan. Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. Pathogens 2024; 13(1): 68 doi: 10.3390/pathogens13010068
|
| 30 |
Fangping Jia, Xiao Hu, Takefumi Kimura, Naoki Tanaka. Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. International Journal of Molecular Sciences 2021; 22(19): 10303 doi: 10.3390/ijms221910303
|
| 31 |
Li LIN, Miao LEI, JiaMan LIN, WenXiang HU. Advances and applications in liver organoid technology. SCIENTIA SINICA Vitae 2023; 53(2): 185 doi: 10.1360/SSV-2021-0283
|
| 32 |
Xiaohe Li, Yinshan Fang, Dingyuan Jiang, Yingying Dong, Yingying Liu, Si Zhang, Jiasen Guo, Chao Qi, Chenjing Zhao, Fangxin Jiang, Yueyue Jin, Jing Geng, Cheng Yang, Hongkai Zhang, Bin Wei, Jiurong Liang, Chen Wang, Huaping Dai, Honggang Zhou, Dianhua Jiang, Wen Ning. Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases. Molecular Therapy 2021; 29(1): 347 doi: 10.1016/j.ymthe.2020.09.031
|
| 33 |
Chen Liang, Yan Li, Miao Bai, Yanxin Huang, Hang Yang, Lei Liu, Shuyue Wang, Chunlei Yu, Zhenbo Song, Yongli Bao, Jingwen Yi, Luguo Sun, Yuxin Li. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo. Pharmacological Research 2020; 153: 104657 doi: 10.1016/j.phrs.2020.104657
|
| 34 |
Lin-you Zou, Na Hu, Ning Wang, Hong-lun Wang. Hepatoprotective Activities of Polysaccharide From the Fruit of Ribes odoratum Wendl. on High-Fat-Sucrose Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Natural Product Communications 2020; 15(8) doi: 10.1177/1934578X20946935
|
| 35 |
Arash Akhavan Rezayat, Mohammad Ghasemi Nour, Yones Bondarsahebi, Seyyed Amin Hozhabrossadati, Fatemeh Amirkhanlou, Shima Akhavan Rezayat, Mohammadali Kiani, Bahareh Imani. The effects of melatonin therapy on the treatment of patients with Non-alcoholic steatohepatitis: A systematic review and Meta-analysis on clinical trial studies. European Journal of Pharmacology 2021; 905: 174154 doi: 10.1016/j.ejphar.2021.174154
|
| 36 |
Tengrui Cao, Chao Tong, Qiang Li, Yumei Han, Aheyeerke Halengbieke, Xuetong Ni, Bo Gao, Deqiang Zheng, Xinghua Yang. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(5): 1245 doi: 10.1016/j.numecd.2024.01.001
|
| 37 |
Dandan Sheng, Shanmin Zhao, Lu Gao, Huifei Zheng, Wenting Liu, Jing Hou, Yuxiang Jin, Fei Ye, Qiudong Zhao, Rong Li, Naping Zhao, Li Zhang, Zhipeng Han, Lixin Wei. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0339-2
|
| 38 |
Gauri S Khatri, Christine Kurian, Asha Anand, Paari KA. Gut Homeostasis; Microbial Cross Talks in Health and Disease Management. Current Research in Nutrition and Food Science Journal 2021; 9(3): 1017 doi: 10.12944/CRNFSJ.9.3.28
|
| 39 |
Jiarong Wang, Wei Jiang, Jiao Xin, Weiju Xue, Congjian Shi, Jiagen Wen, Yan Huang, Chengmu Hu. Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.717276
|
| 40 |
Maria-Angeles Aller, Javier Blanco-Rivero, Natalia Arias, Luis Santamaria, Jaime Arias. The Lymphatic Headmaster of the Mast Cell-Related Splanchnic Inflammation in Portal Hypertension. Cells 2019; 8(7): 658 doi: 10.3390/cells8070658
|
| 41 |
Qiuyue Ma, Fude Yang, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu. Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study. Hepatology International 2021; 15(1): 127 doi: 10.1007/s12072-020-10132-z
|
| 42 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
| 43 |
Robin D. Tucker, Victor Ciofoaia, Sandeep Nadella, Martha D. Gay, Hong Cao, Matthew Huber, Anita Safronenka, Narayan Shivapurkar, Bhaskar Kallakury, Annie J. Kruger, Alexander H. K. Kroemer, Jill P. Smith. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. Digestive Diseases and Sciences 2020; 65(1): 189 doi: 10.1007/s10620-019-05722-3
|
| 44 |
Xiaohua Duan, Jianlin Lv, Hebei Jiang, Kefei Zheng, Yulin Chen, Enfa Zhao. Inflammatory Cytokines, Adipocytokines, and Th17/Treg Balance in Patients with Nonalcoholic Fatty Liver Disease following Administration of Dahuang Zhechong Pills. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/8560831
|
| 45 |
Naoyuki Fujimori, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Shun‐ichi Wakabayashi, Yuki Yamashita, Ayumi Sugiura, Jonathan Pham, Sai P. Pydi, Kenji Sano, Satoru Joshita, Takeji Umemura. 2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease. Hepatology Research 2022; 52(4): 352 doi: 10.1111/hepr.13745
|
| 46 |
Patrice Lazure, Jeremy W. Tomlinson, Kris V. Kowdley, Paolo Magni, Raul D. Santos, Ginny Jacobs, Suzanne Murray. Clinical practice gaps and challenges in non‐alcoholic steatohepatitis care: An international physician needs assessment. Liver International 2022; 42(8): 1772 doi: 10.1111/liv.15324
|
| 47 |
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
|
| 48 |
Lingzhi Wang, Wenxi Li, Yinggang Li, Gengrui Chen, Lijuan Zhao, Wu Li, Shengwei Wang, Chunming Wang, Yanxian Feng, Yibo Zhang. Dried tangerine peel polysaccharide (DTPP) alleviates hepatic steatosis by suppressing TLR4/MD-2-mediated inflammation and endoplasmic reticulum stress. Bioorganic Chemistry 2024; 147: 107369 doi: 10.1016/j.bioorg.2024.107369
|
| 49 |
Pan Diao, Xiaojing Wang, Fangping Jia, Takefumi Kimura, Xiao Hu, Saki Shirotori, Ibuki Nakamura, Yoshiko Sato, Jun Nakayama, Kyoji Moriya, Kazuhiko Koike, Frank J Gonzalez, Toshifumi Aoyama, Naoki Tanaka. A saturated fatty acid-rich diet enhances hepatic lipogenesis and tumorigenesis in HCV core gene transgenic mice. The Journal of Nutritional Biochemistry 2020; 85: 108460 doi: 10.1016/j.jnutbio.2020.108460
|
| 50 |
Martha D. Gay, Hong Cao, Narayan Shivapurkar, Sivanesan Dakshanamurthy, Bhaskar Kallakury, Robin D. Tucker, John Kwagyan, Jill P. Smith. Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome. International Journal of Molecular Sciences 2022; 23(3): 1899 doi: 10.3390/ijms23031899
|
| 51 |
Di Cao, Mengyi Li, Yang Liu, He Jin, Dawei Yang, Hui Xu, Han Lv, JIa Liu, Peng Zhang, Zhongtao Zhang, Zhenghan Yang. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00821-6
|
| 52 |
Atsuhiro Nagasaki, Shinnichi Sakamoto, Toshiki Arai, Minami Kato, Eri Ishida, Hisako Furusho, Makiko Fujii, Takashi Takata, Mutsumi Miyauchi. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. Journal of Clinical Periodontology 2021; 48(10): 1367 doi: 10.1111/jcpe.13523
|
| 53 |
Khaled Alkhuder. Raman scattering-based optical sensing of chronic liver diseases. Photodiagnosis and Photodynamic Therapy 2023; 42: 103505 doi: 10.1016/j.pdpdt.2023.103505
|
| 54 |
Zhuang Li, Haozhen Yu, Jun Li. Identification of Key Endoplasmic Reticulum Stress-Related Genes in Non-Alcoholic Fatty Liver Disease. BioMedInformatics 2022; 2(3): 424 doi: 10.3390/biomedinformatics2030027
|
| 55 |
Yin-Zhao Jia, Qiao-Juan Mei, Yong Zhang. MiR-484 participates in non-alcoholic fatty liver injury by targeting SIRT1 to mediate cell apoptosis. World Chinese Journal of Digestology 2021; 29(8): 389 doi: 10.11569/wcjd.v29.i8.389
|
| 56 |
Elham Nazari, Ghazaleh Khalili-Tanha, Alireza Asadnia, Ghazaleh Pourali, Mina Maftooh, Majid Khazaei, Mohammadreza Nasiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad Ali Kiani, Amir Avan. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46711-x
|
| 57 |
Jian ZHOU, Sian XU, Yue ZHU, Xin LI, Ao WANG, Junfang HU, Li LI, Yan LIU. Inhibition of neuropilin-1 improves non-alcoholic fatty liver disease in high-fat-diet induced obese mouse. Minerva Endocrinology 2023; 48(2) doi: 10.23736/S2724-6507.22.03895-7
|
| 58 |
Ali Canbay, Nandita Kachru, Jennifer Scarlet Haas, Jan‐Peter Sowa, Dominic Meise, Ahmet Burak Ozbay. Patterns and predictors of mortality and disease progression among patients with non‐alcoholic fatty liver disease . Alimentary Pharmacology & Therapeutics 2020; 52(7): 1185 doi: 10.1111/apt.16016
|
| 59 |
Carolina Guzmán, Miriam G. Bautista-Ubaldo, Adriana Campos-Espinosa, Ivette I. Romero-Bello, Ángel Daniel Santana-Vargas, Gabriela Gutierrez-Reyes. Insulin-like Growth Factor Binding Proteins and Cellular Senescence Are Involved in the Progression of Non-Alcoholic Fatty Liver Disease and Fibrosis in a Mouse Model. Medicina 2024; 60(3): 429 doi: 10.3390/medicina60030429
|
| 60 |
Muhammad Hussain, Xiaodong Li, Lu Liu, Lina Wang, Abdul Qayum, Baigalmaa Purevsuren, Arif Hussain. Characterization and anti-hyper-lipidemic effect of micro encapsulated phytosterol enriched cheddar cheese. LWT 2020; 134: 110114 doi: 10.1016/j.lwt.2020.110114
|
| 61 |
Eunüs S. Ali, Nikolai Petrovsky. Calcium Signaling As a Therapeutic Target for Liver Steatosis. Trends in Endocrinology & Metabolism 2019; 30(4): 270 doi: 10.1016/j.tem.2019.02.005
|
| 62 |
Pan Diao, Yaping Wang, Fangping Jia, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Jun Nakayama, Naoki Tanaka. Dietary Fat Composition Affects Hepatic Angiogenesis and Lymphangiogenesis in Hepatitis C Virus Core Gene Transgenic Mice. Liver Cancer 2023; 12(1): 57 doi: 10.1159/000525546
|
| 63 |
Noemí Cabré, Fedra Luciano‐Mateo, Gerard Baiges‐Gayà, Salvador Fernández‐Arroyo, Elisabet Rodríguez‐Tomàs, Anna Hernández‐Aguilera, Marta París, Fàtima Sabench, Daniel Del Castillo, José López‐Miranda, Javier A. Menéndez, Jordi Camps, Jorge Joven. Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2020; 51(3): 374 doi: 10.1111/apt.15606
|
| 64 |
Marwa Abdelgwad, Reem Zakaria, Samar Marzouk, Dina Sabry, Rasha Ahmed, Hedy Ayman Badary, Mai Samir. The Emerging Role of Circular RNA Homeodomain Interacting Protein Kinase 3 and Circular RNA 0046367 through Wnt/Beta-Catenin Pathway on the Pathogenesis of Nonalcoholic Steatohepatitis in Egyptian Patients. Reports of Biochemistry and Molecular Biology 2023; 11(4): 614 doi: 10.52547/rbmb.11.4.614
|
| 65 |
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Ji Hye Kim, Byung-gyu Kim, Bokyung Lee, Sung Mun Bae, Eun-Kyung Kim. AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling. Foods 2021; 10(9): 1973 doi: 10.3390/foods10091973
|
| 66 |
Xiao-lin Zhang, Ya-nan Wang, Lu-yao Ma, Zhong-sheng Liu, Fei Ye, Jian-hong Yang. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. Acta Pharmacologica Sinica 2020; 41(3): 383 doi: 10.1038/s41401-019-0311-z
|
| 67 |
Miao Shen, Hanghai Pan, Jinjing Ke, Fei Zhao. NF‐κB‐upregulated miR‐155‐5p promotes hepatocyte mitochondrial dysfunction to accelerate the development of nonalcoholic fatty liver disease through downregulation of STC1. Journal of Biochemical and Molecular Toxicology 2022; 36(6) doi: 10.1002/jbt.23025
|
| 68 |
Guoqing Huang, Qiankai Jin, Yushan Mao. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study. Journal of Medical Internet Research 2023; 25: e46891 doi: 10.2196/46891
|
| 69 |
Pan Diao, Fangping Jia, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Takero Nakajima, Toshifumi Aoyama, Kyoji Moriya, Kazuhiko Koike, Naoki Tanaka. Mechanisms of Steatosis-Derived Hepatocarcinogenesis: Lessons from HCV Core Gene Transgenic Mice. Engineering 2021; 7(12): 1797 doi: 10.1016/j.eng.2021.08.019
|
| 70 |
|
| 71 |
Mirah Khalid Alshehhi, Asiya Nazir. Microbiome Therapeutics. 2023; : 139 doi: 10.1016/B978-0-323-99336-4.00010-0
|
| 72 |
Yuping Zeng, Xia Wang, He He, Lidan Yang, Shuangqin Li, Zhenmei An. Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3915431
|
| 73 |
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Tomoo Yamazaki, Takahito Katsuyama, Yuichi Iwashita, Jonathan Pham, Satoru Joshita, Sai P. Pydi, Takeji Umemura. Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. Liver International 2021; 41(3): 505 doi: 10.1111/liv.14776
|
| 74 |
Antoni Sicras-Mainar, Rocío Aller , Javier Crespo Garcia, José Luis Calleja, Juan Turnes, Manuel Romero-Gómez, Salvador Augustín. Overall clinical and economic impact of non-alcoholic fatty liver disease. Revista Española de Enfermedades Digestivas 2020; doi: 10.17235/reed.2020.7238/2020
|
| 75 |
Ralf Glatthar, Robert H. Arch. Burger's Medicinal Chemistry and Drug Discovery. 2021; : 1 doi: 10.1002/0471266949.bmc274
|
| 76 |
Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos. Is there a role of lipid-lowering therapies in the management of fatty liver disease?. World Journal of Hepatology 2022; 14(1): 119-139 doi: 10.4254/wjh.v14.i1.119
|
| 77 |
Nuria Perez-Diaz-del-Campo, Itziar Abete, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease. Nutrients 2020; 12(5): 1260 doi: 10.3390/nu12051260
|
| 78 |
Mo'tasem M. Alsmadi, Nour M AL‐Daoud, Mays M. Jaradat, Saja B. Alzughoul, Amani D. Abu Kwiak, Salam S. Abu Laila, Ayat J. Abu Shameh, Mohammad K. Alhazabreh, Sana'a A. Jaber, Hala T. Abu Kassab. Physiologically‐based pharmacokinetic model for alectinib, ruxolitinib, and panobinostat in the presence of cancer, renal impairment, and hepatic impairment. Biopharmaceutics & Drug Disposition 2021; 42(6): 263 doi: 10.1002/bdd.2282
|
| 79 |
Takefumi Kimura. Advancements in the Treatment Landscape of Hepatocellular Carcinoma. Cancers 2024; 16(5): 1054 doi: 10.3390/cancers16051054
|
| 80 |
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Lorraine J. Gudas. Retinoids in the Pathogenesis and Treatment of Liver Diseases. Nutrients 2022; 14(7): 1456 doi: 10.3390/nu14071456
|
| 81 |
Shilpa Chawla, Amitava Das. Stem Cells and Signaling Pathways. 2024; : 101 doi: 10.1016/B978-0-443-18800-8.00014-9
|
| 82 |
Bartosz Fotschki, Michał Sójka, Monika Kosmala, Jerzy Juśkiewicz. Prebiotics Together with Raspberry Polyphenolic Extract Mitigate the Development of Nonalcoholic Fatty Liver Diseases in Zucker Rats. Nutrients 2023; 15(14): 3115 doi: 10.3390/nu15143115
|
| 83 |
Rui Huang, Jian-Gao Fan, Jun-Ping Shi, Yi-Min Mao, Bing-Yuan Wang, Jing-Min Zhao, Lun-Gen Lu, Bi-Hui Zhong, Zheng-Sheng Zou, You-Qing Xu, Yi-Nong Ye, Long-Gen Liu, Lian-Jie Lin, Hui-Ying Rao, Lai Wei. Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China. Quality of Life Research 2023; 32(3): 915 doi: 10.1007/s11136-022-03305-w
|
| 84 |
清莲 宋. Progress in the Study of the Pathogenesis of Chronic Kidney Disease Associated with Nonalcoholic Fatty Liver Disease. Advances in Clinical Medicine 2019; 9(09): 1073 doi: 10.12677/ACM.2019.99165
|
| 85 |
Wen Wang, Xiaojing Liu, Peiyao Wei, Feng Ye, Yunru Chen, Lei Shi, Xi Zhang, Jianzhou Li, Shumei Lin, Xueliang Yang. SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.862278
|
| 86 |
Xiaojing Wang, Naoki Tanaka, Xiao Hu, Takefumi Kimura, Yu Lu, Fangping Jia, Yoshiko Sato, Jun Nakayama, Kyoji Moriya, Kazuhiko Koike, Toshifumi Aoyama. A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic mice. Archives of Toxicology 2019; 93(6): 1713 doi: 10.1007/s00204-019-02440-7
|
| 87 |
Maitane González-Arceo, Jenifer Trepiana, Leixuri Aguirre, Jone Ibarruri, Marta Martínez-Sanz, Marta Cebrián, Isidra Recio, María P. Portillo, Saioa Gómez-Zorita. Anti-Steatotic Effects of Chlorella vulgaris, Nannochloropsis gaditana and Gracilaria vermiculophylla Algae Extracts in AML-12 Hepatocytes. Nutrients 2023; 15(8): 1960 doi: 10.3390/nu15081960
|
| 88 |
Yaping Wang, Takero Nakajima, Frank J. Gonzalez, Naoki Tanaka. PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. International Journal of Molecular Sciences 2020; 21(6): 2061 doi: 10.3390/ijms21062061
|
| 89 |
Xiaojie Lu, Yue Jing, Xiaofei Zhou, Naisheng Zhang, Jiandong Tai, Yongguo Cao. Bacillus licheniformis Zhengchangsheng® Inhibits Obesity by Regulating the AMP-Activated Protein Kinase Signaling Pathway. Probiotics and Antimicrobial Proteins 2021; 13(6): 1658 doi: 10.1007/s12602-021-09792-6
|
| 90 |
J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts. Actas Dermo-Sifiliográficas 2023; 114(5): T392 doi: 10.1016/j.ad.2023.04.013
|
| 91 |
Yuxin Luo, Jinbo Guo, Wenxiu Jia, Mengyao Wu, Fengrong Yin, Guochao Niu, David Q. Shih, Stephan R. Targan, Xiaolan Zhang, Ramoji Kosuru. TNF‐Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/3877617
|
| 92 |
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Masahide Yazaki. Citrin Deficiency: Clinical and Nutritional Features. Nutrients 2023; 15(10): 2284 doi: 10.3390/nu15102284
|
| 93 |
Roshan Shafiha, Basak Bahcivanci, Georgios V. Gkoutos, Animesh Acharjee. Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers. Biomedicines 2021; 9(11): 1636 doi: 10.3390/biomedicines9111636
|
| 94 |
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, Arun J. Sanyal. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obesity and Metabolism 2021; 23(5): 1069 doi: 10.1111/dom.14322
|
| 95 |
Xiaojing Wang, Liangjing Wang, Lin Geng, Naoki Tanaka, Bin Ye. Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner. International Journal of Molecular Sciences 2023; 24(6): 5843 doi: 10.3390/ijms24065843
|
| 96 |
Carlos Eduardo da Silva Filomeno, Michele Costa-Silva, Christiane Leal Corrêa, Renata Heisler Neves, Carlos Alberto Mandarim-de-Lacerda, José Roberto Machado-Silva. The acute schistosomiasis mansoni ameliorates metabolic syndrome in the C57BL/6 mouse model. Experimental Parasitology 2020; 212: 107889 doi: 10.1016/j.exppara.2020.107889
|
| 97 |
Soo Young Choe, Yoonhee Seo, Chae Young Bang, Seok Hoon Woo, Moonkyu Kang. Protective effects of Gymnaster koraiensis extract on high fat diet-induced fatty liver in mice. Advances in Traditional Medicine 2021; 21(2): 361 doi: 10.1007/s13596-020-00434-w
|
| 98 |
Mehdi Afsharinasab, Maryam Mohammad-Sadeghipour, Mohammad Reza Hajizadeh, Alireza Khoshdel, Vahid Mirzaiey, Mehdi Mahmoodi. The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. Saudi Journal of Biological Sciences 2020; 27(8): 2031 doi: 10.1016/j.sjbs.2020.04.037
|
| 99 |
Takefumi Kimura, Simran Singh, Naoki Tanaka, Takeji Umemura. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.773432
|
| 100 |
Raj A. Shah, Naim Alkhouri, Kris V Kowdley. Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists. Expert Opinion on Emerging Drugs 2020; 25(3): 251 doi: 10.1080/14728214.2020.1796968
|
| 101 |
J Wang, G Chen. Dimethylacetamide-induced toxic hepatitis in spandex workers: clinical presentation and treatment outcomes. QJM: An International Journal of Medicine 2020; 113(5): 324 doi: 10.1093/qjmed/hcz282
|
| 102 |
Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29657
|
| 103 |
Shu Jia, Lianyu Jin, Xiaoyan Cheng, Jingyi Wu, Xiaokun Yao, Jingping Shao, Congcong Zhang, Danwei Cen, Bin Cheng, Jing Wang, Lei Chen, Xiaomin Yao. Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in mice. Drug Development and Industrial Pharmacy 2022; 48(6): 247 doi: 10.1080/03639045.2022.2106238
|
| 104 |
Fangping Jia, Pan Diao, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Makoto Nakamuta, Ibuki Nakamura, Saki Shirotori, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Frank J. Gonzalez, Jun Nakayama, Toshifumi Aoyama, Naoki Tanaka. Dietary Restriction Suppresses Steatosis-Associated Hepatic Tumorigenesis in Hepatitis C Virus Core Gene Transgenic Mice. Liver Cancer 2020; 9(5): 529 doi: 10.1159/000508308
|
| 105 |
Vinay Kumar Kohli, Chitra Kohli, Akanksha Singh. Comprehensive Multiple-Choice Questions in Pathology. 2022; : 9 doi: 10.1007/978-3-031-08767-7_2
|